Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3

Yonghao Hou, P. Artur Plett, David A. Ingram, Gangaraju Rajashekhar, Christie M. Orschell, Mervin C. Yoder, Keith L. March, Matthias Clauss

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective: Recruitment of endothelial progenitor cells to the sites of ischemia has recently been suggested as a mechanism of tissue repair. Here we address the hypothesis that the hypoxia-inducible full-length endothelial-monocyte-activating polypeptide II (EMAP II) provides a mechanism to recruit late outgrowth highly proliferating endothelial progenitor cells (EPCs). Materials and Methods: We tested in a transwell migration assay EMAP II for its ability to induce migration of EPCs. Furthermore, we measured changes in cellular calcium levels in EPC to assess the ability of EMAP II to induce intracellular signaling. Finally, we employed neutralizing antibodies and binding competition studies in order to identify the receptor mediating these activities of EMAP II in EPCs. Results: EMAP II elicits dose-dependent migration and intracellular calcium mobilization in EPCs. Functional blocking and binding studies with radiolabeled interferon-γ-induced protein (IP-10) indicate that EMAP II employs the CXCR3 receptor for these activities in EPCs. Indeed, EMAP II-induced migration of EPCs can be abolished by prior treatment of cells with anti-CXCR3 antibodies or with IP-10. Conclusions: These data suggests a novel function for EMAP II and a hitherto undescribed role of the CXCR3 chemokine receptor in EPC recruitment.

Original languageEnglish (US)
Pages (from-to)1125-1132
Number of pages8
JournalExperimental Hematology
Volume34
Issue number8
DOIs
StatePublished - Aug 1 2006

Fingerprint

Chemokine Receptors
CXCR3 Receptors
Calcium
small inducible cytokine subfamily E, member 1
Endothelial Progenitor Cells
Neutralizing Antibodies
Interferons
Anti-Idiotypic Antibodies
Ischemia

ASJC Scopus subject areas

  • Molecular Biology
  • Hematology
  • Genetics
  • Cell Biology
  • Cancer Research

Cite this

Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. / Hou, Yonghao; Plett, P. Artur; Ingram, David A.; Rajashekhar, Gangaraju; Orschell, Christie M.; Yoder, Mervin C.; March, Keith L.; Clauss, Matthias.

In: Experimental Hematology, Vol. 34, No. 8, 01.08.2006, p. 1125-1132.

Research output: Contribution to journalArticle

@article{f043c96d6f9843dd91f062384c4149b5,
title = "Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3",
abstract = "Objective: Recruitment of endothelial progenitor cells to the sites of ischemia has recently been suggested as a mechanism of tissue repair. Here we address the hypothesis that the hypoxia-inducible full-length endothelial-monocyte-activating polypeptide II (EMAP II) provides a mechanism to recruit late outgrowth highly proliferating endothelial progenitor cells (EPCs). Materials and Methods: We tested in a transwell migration assay EMAP II for its ability to induce migration of EPCs. Furthermore, we measured changes in cellular calcium levels in EPC to assess the ability of EMAP II to induce intracellular signaling. Finally, we employed neutralizing antibodies and binding competition studies in order to identify the receptor mediating these activities of EMAP II in EPCs. Results: EMAP II elicits dose-dependent migration and intracellular calcium mobilization in EPCs. Functional blocking and binding studies with radiolabeled interferon-γ-induced protein (IP-10) indicate that EMAP II employs the CXCR3 receptor for these activities in EPCs. Indeed, EMAP II-induced migration of EPCs can be abolished by prior treatment of cells with anti-CXCR3 antibodies or with IP-10. Conclusions: These data suggests a novel function for EMAP II and a hitherto undescribed role of the CXCR3 chemokine receptor in EPC recruitment.",
author = "Yonghao Hou and Plett, {P. Artur} and Ingram, {David A.} and Gangaraju Rajashekhar and Orschell, {Christie M.} and Yoder, {Mervin C.} and March, {Keith L.} and Matthias Clauss",
year = "2006",
month = "8",
day = "1",
doi = "10.1016/j.exphem.2006.05.021",
language = "English (US)",
volume = "34",
pages = "1125--1132",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3

AU - Hou, Yonghao

AU - Plett, P. Artur

AU - Ingram, David A.

AU - Rajashekhar, Gangaraju

AU - Orschell, Christie M.

AU - Yoder, Mervin C.

AU - March, Keith L.

AU - Clauss, Matthias

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Objective: Recruitment of endothelial progenitor cells to the sites of ischemia has recently been suggested as a mechanism of tissue repair. Here we address the hypothesis that the hypoxia-inducible full-length endothelial-monocyte-activating polypeptide II (EMAP II) provides a mechanism to recruit late outgrowth highly proliferating endothelial progenitor cells (EPCs). Materials and Methods: We tested in a transwell migration assay EMAP II for its ability to induce migration of EPCs. Furthermore, we measured changes in cellular calcium levels in EPC to assess the ability of EMAP II to induce intracellular signaling. Finally, we employed neutralizing antibodies and binding competition studies in order to identify the receptor mediating these activities of EMAP II in EPCs. Results: EMAP II elicits dose-dependent migration and intracellular calcium mobilization in EPCs. Functional blocking and binding studies with radiolabeled interferon-γ-induced protein (IP-10) indicate that EMAP II employs the CXCR3 receptor for these activities in EPCs. Indeed, EMAP II-induced migration of EPCs can be abolished by prior treatment of cells with anti-CXCR3 antibodies or with IP-10. Conclusions: These data suggests a novel function for EMAP II and a hitherto undescribed role of the CXCR3 chemokine receptor in EPC recruitment.

AB - Objective: Recruitment of endothelial progenitor cells to the sites of ischemia has recently been suggested as a mechanism of tissue repair. Here we address the hypothesis that the hypoxia-inducible full-length endothelial-monocyte-activating polypeptide II (EMAP II) provides a mechanism to recruit late outgrowth highly proliferating endothelial progenitor cells (EPCs). Materials and Methods: We tested in a transwell migration assay EMAP II for its ability to induce migration of EPCs. Furthermore, we measured changes in cellular calcium levels in EPC to assess the ability of EMAP II to induce intracellular signaling. Finally, we employed neutralizing antibodies and binding competition studies in order to identify the receptor mediating these activities of EMAP II in EPCs. Results: EMAP II elicits dose-dependent migration and intracellular calcium mobilization in EPCs. Functional blocking and binding studies with radiolabeled interferon-γ-induced protein (IP-10) indicate that EMAP II employs the CXCR3 receptor for these activities in EPCs. Indeed, EMAP II-induced migration of EPCs can be abolished by prior treatment of cells with anti-CXCR3 antibodies or with IP-10. Conclusions: These data suggests a novel function for EMAP II and a hitherto undescribed role of the CXCR3 chemokine receptor in EPC recruitment.

UR - http://www.scopus.com/inward/record.url?scp=33746031420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746031420&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2006.05.021

DO - 10.1016/j.exphem.2006.05.021

M3 - Article

C2 - 16863920

AN - SCOPUS:33746031420

VL - 34

SP - 1125

EP - 1132

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 8

ER -